financetom
Business
financetom
/
Business
/
On This Day 15 Years Ago, Elon Musk's Tesla Took A Risk On The Public Markets — Now It's Paid Off Nearly 300 Times Over
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
On This Day 15 Years Ago, Elon Musk's Tesla Took A Risk On The Public Markets — Now It's Paid Off Nearly 300 Times Over
Jun 29, 2025 10:56 AM

Tesla Inc. ( TSLA ) marks its 15th anniversary of its initial public offering (IPO) with a staggering 300-fold surge in its stock value.

Tesla’s IPO occurred 15 years ago, on June 29 2010, with the company generating around $150 million in revenue, primarily from the Roadster, its two-seat electric sports car. The Model S sedan, targeting the premium vehicle market, was still two years away from launch.

The IPO was a gamble on CEO Elon Musk‘s ability to create a range of mass-market electric vehicles and build an automaker far from the Detroit auto hub, centered instead on Silicon Valley.

An investor who put $10,000 in Tesla’s stock at the IPO and held onto the shares would now have a stake worth nearly $3 million. Tesla is currently the eighth most-valuable publicly traded U.S. company, boasting a market cap of over $1 trillion.

Tesla’s financial success over the past decade has been shaped by the top-selling Model Y SUV and Model 3 sedan, along with sales of environmental regulatory credits.

Also Read: Elon Musk Calls Trump’s Megabill ‘Political Suicide,’ Says ‘It Is Utterly Insane and Destructive,’ Will ‘Destroy Millions of Jobs in America’

Musk, now the world’s richest person, has told investors that the reason to buy and own Tesla stock from here has almost nothing to do with selling cars to consumers.

"If somebody doesn't believe Tesla's going to solve autonomy, I think they should not be an investor in the company," Musk said, and as reported by CNBC, on an earnings call last year.

Instead, he sees the potential in Tesla’s Optimus humanoid robots and the company’s autonomous driving technology.

While Tesla continues to enjoy a loyal fan base and support from a number of bullish analysts, Wall Street remains cautious about Elon Musk's ambitious projections—many viewing them as already priced into the stock.

Tesla’s stock is down about 20% this year, underperforming major U.S. indexes and lagging behind all of its megacap tech peers. Only Apple, with a year-to-date decline of 19.7%, comes close.

Earlier in June, Tesla’s vice president of Optimus robotics, Milan Kovac, announced his departure from the company after a nine-year tenure.

Despite these challenges, Tesla investors have learned that volatility is a big part of the company’s story, with the stock experiencing significant gains or losses on more than 40 occasions in the past 15 years.

Read Next

Musk vs. Trump: Tesla Slashes Cybertruck Prices After Feud Heats Up, Here’s How Much You Need To Pay for It Now

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioNTech Announces Settlement With National Institutes of Health, University of Pennsylvania Over Royalty Claims
BioNTech Announces Settlement With National Institutes of Health, University of Pennsylvania Over Royalty Claims
Dec 27, 2024
12:11 PM EST, 12/27/2024 (MT Newswires) -- BioNTech (BNTX) on Friday announced separate agreements with the US National Institutes of Health and the University of Pennsylvania to settle royalty claims related to sales of its COVID-19 vaccine co-developed with pharmaceutical giant Pfizer ( PFE ) . Under the terms of a Dec. 20 deal, the German drugmaker agreed to pay...
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
Dec 27, 2024
By Sneha S K and Sriparna Roy Dec 27 (Reuters) - The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ( BMY ) blockbuster cancer drug, Opdivo. Opdivo is part of a class of drugs called PD-1 inhibitors, which enhance the immune system's ability to fight cancer by removing...
Looking At Upstart Hldgs's Recent Unusual Options Activity
Looking At Upstart Hldgs's Recent Unusual Options Activity
Dec 27, 2024
Deep-pocketed investors have adopted a bearish approach towards Upstart Hldgs ( UPST ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in UPST usually suggests something big is about to happen. We gleaned this information...
Netflix Sets Streaming Record for NFL Games With 65 Million US Christmas Viewers
Netflix Sets Streaming Record for NFL Games With 65 Million US Christmas Viewers
Dec 27, 2024
12:10 PM EST, 12/27/2024 (MT Newswires) -- Netflix ( NFLX ) and the National Football League set new records on Christmas Day, attracting almost 65 million US viewers, according to Nielsen data, the streaming company said Thursday. The games between the Baltimore Ravens and Houston Texans and the Kansas City Chiefs against the Pittsburgh Steelers became the most-streamed NFL games...
Copyright 2023-2026 - www.financetom.com All Rights Reserved